Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Hadigan

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2019
Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral ClearanceChloe S Chaudhury, Thomas Mee, Cheryl Chairez, et al.
Clinical Pharmacology and Therapeutics|October 19, 2020
Quantitative Benefit-Risk Assessment of P-gp-Mediated Drug-Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal ImpairmentKarthik Lingineni, Nashid Farhan, Sarah Kim, et al.
AIDS (London, England)|March 18, 2011
Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIVLaura W Musselwhite, Virginia Sheikh, Thomas D Norton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2020
Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia CohortJomy M George, Safia S Kuriakose, Anne Monroe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2014
Increased coronary vessel wall thickness in HIV-infected young adultsKhaled Z Abd-Elmoniem, Aylin B Unsal, Sarah Eshera, et al.
Radiology. Cardiothoracic Imaging|February 21, 2020
Sexual Dimorphism of Coronary Artery Disease in a Low- and Intermediate-Risk Asymptomatic Population: Association with Coronary Vessel Wall Thickness at MRI in WomenAhmed M Ghanem, Jatin Raj Matta, Reham Elgarf, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 9, 2020
Brief Report: Adiponectin Levels Linked to Subclinical Myocardial Fibrosis in HIVJulia B Balmaceda, Khaled Z Abd-Elmoniem, Chia Ying Liu, et al.
The Pediatric Infectious Disease Journal|October 18, 2016
T-cell Activation and E-selectin Are Associated With Coronary Plaque in HIV-infected Young AdultsAviva S Mattingly, Aylin B Unsal, Julia B Purdy, et al.
Circulation|December 7, 2016
Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy VolunteersLori A Gordon, Parag Kumar, Kristina M Brooks, et al.
Hepatology International|March 6, 2019
Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patientsBenjamin Emmanuel, Samer S El-Kamary, Laurence S Magder, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2019
Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral ClearanceChloe S Chaudhury, Thomas Mee, Cheryl Chairez, et al.
Clinical Pharmacology and Therapeutics|October 19, 2020
Quantitative Benefit-Risk Assessment of P-gp-Mediated Drug-Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal ImpairmentKarthik Lingineni, Nashid Farhan, Sarah Kim, et al.
AIDS (London, England)|March 18, 2011
Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIVLaura W Musselwhite, Virginia Sheikh, Thomas D Norton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2020
Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia CohortJomy M George, Safia S Kuriakose, Anne Monroe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2014
Increased coronary vessel wall thickness in HIV-infected young adultsKhaled Z Abd-Elmoniem, Aylin B Unsal, Sarah Eshera, et al.
Radiology. Cardiothoracic Imaging|February 21, 2020
Sexual Dimorphism of Coronary Artery Disease in a Low- and Intermediate-Risk Asymptomatic Population: Association with Coronary Vessel Wall Thickness at MRI in WomenAhmed M Ghanem, Jatin Raj Matta, Reham Elgarf, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 9, 2020
Brief Report: Adiponectin Levels Linked to Subclinical Myocardial Fibrosis in HIVJulia B Balmaceda, Khaled Z Abd-Elmoniem, Chia Ying Liu, et al.
The Pediatric Infectious Disease Journal|October 18, 2016
T-cell Activation and E-selectin Are Associated With Coronary Plaque in HIV-infected Young AdultsAviva S Mattingly, Aylin B Unsal, Julia B Purdy, et al.
Circulation|December 7, 2016
Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy VolunteersLori A Gordon, Parag Kumar, Kristina M Brooks, et al.
Hepatology International|March 6, 2019
Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patientsBenjamin Emmanuel, Samer S El-Kamary, Laurence S Magder, et al.
Pageof 10